PATENT CLAIM ANALYSIS

Application Number: 16035503
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "452000"]

Abstract:
The present disclosure relates to pharmaceutical formulations of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid and methods of use thereof.

Claim (Index 10):
The tablet of  claim 8 , wherein the tablet comprises a tablet core and a coating and the tablet core comprises the active ingredient, and the coating comprises the photostabilizing agent, and further wherein the photostabilizing agent comprises, from about 0.1 to about 2 mg/cm 2  titanium dioxide and at least one additional dye selected from the group consisting of:\n from about 0.1 to about 0.4 mg/cm 2  Allura Red AC; from about 0.1 to about 0.4 mg/cm 2  Allura Red AC in aluminum lake; from about 0.004 to about 0.4 mg/cm 2  iron oxide red; from about 0.009 to about 0.2 mg/cm 2  iron oxide yellow; from about 0.01 to 0.03 mg/cm 2  Sunset Yellow FCF; and from about 0.01 to 0.03 mg/cm 2  Sunset Yellow FCF in aluminum lake; wherein the amount of photostabilizing agent is based on surface area of the tablet core.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13942370', '15585903', '15538227', '12015275', '15133104']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7677529837191827
- 35 USC 102 Novelty (BERT): 0.4895343857139245
- Combined Prediction Score: 0.7399311239186569
- Mean Citation Score: 191.677378
- Max Citation Score: 197.56956
- Similarity Product: 133.70750868631123

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test